Concepedia

Atsuo Tahara

AT

Statistics

Publications

60

Citations

2.7K

H-Index

28

Active since

1963

Affiliations

Astellas Pharma (Japan)(Current)

Astellas Pharma (Netherlands)

Kissei Pharmaceutical (Japan)

Drug Discovery Laboratory (Norway)

Yamaha (Japan)

Atsuo Tahara is an author at Astellas Pharma (Japan) specializing in medicine, physiology, and pharmacology.

ORCID

Top concepts

Publications per year

1963–2021

60

Publications

60

Effects of SGLT2 selective inhibitor ipragliflozin on hyperglycemia, hyperlipidemia, hepatic steatosis, oxidative stress, inflammation, and obesity in type 2 diabetic mice

Atsuo Tahara, Eiji Kurosaki, Masanori Yokono et al. · European Journal of Pharmacology · 2013 · 305 citations

, , +10

SGLT2 selective inhibitor ipragliflozin reduces body fat mass by increasing fatty acid oxidation in high-fat diet-induced obese rats

Masanori Yokono, Toshiyuki Takasu, Yuka Hayashizaki et al. · European Journal of Pharmacology · 2014 · 190 citations · Full text

Characterization and comparison of sodium-glucose cotransporter 2 inhibitors in pharmacokinetics, pharmacodynamics, and pharmacologic effects

Atsuo Tahara, Toshiyuki Takasu, Masanori Yokono et al. · Journal of Pharmacological Sciences · 2016 · 144 citations · Full text

Pharmacological Profile of YM087, A Novel Potent Nonpeptide Vasopressin V1A and V2 Receptor Antagonist, in Vitro and in Vivo

Atsuo Tahara, Yuichi Tomura, Koh‐ichi Wada et al. · Journal of Pharmacology and Experimental Therapeutics · 1997 · 139 citations · Full text

Molecular Cloning and Characterization of Rat V1B Vasopressin Receptor: Evidence for Its Expression in Extrapituitary Tissues

Masayuki Saito, Toru Sugimoto, Atsuo Tahara et al. · Biochemical and Biophysical Research Communications · 1995 · 123 citations

, , +10

1–5 of 60